Search details
1.
Infection and transmission of SARS-CoV-2 depend on heparan sulfate proteoglycans.
EMBO J
; 40(20): e106765, 2021 10 18.
Article
in English
| MEDLINE | ID: mdl-34510494
2.
SARS-CoV-2 suppresses TLR4-induced immunity by dendritic cells via C-type lectin receptor DC-SIGN.
PLoS Pathog
; 19(10): e1011735, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37844099
3.
SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs.
Eur J Immunol
; 52(4): 646-655, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35099061
4.
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.
Lancet
; 389(10070): 709-717, 2017 02 18.
Article
in English
| MEDLINE | ID: mdl-28087069
5.
Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients.
J Infect Dis
; 215(9): 1421-1429, 2017 05 01.
Article
in English
| MEDLINE | ID: mdl-28368488
6.
Specific plasma microRNAs are associated with CD4 + T-cell recovery during suppressive antiretroviral therapy for HIV-1.
AIDS
; 38(6): 791-801, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38300257
7.
Gag sequence variation in a human immunodeficiency virus type 1 transmission cluster influences viral replication fitness.
J Gen Virol
; 94(Pt 2): 354-359, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23136365
8.
Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.
Microbiol Spectr
; 11(3): e0115523, 2023 06 15.
Article
in English
| MEDLINE | ID: mdl-37166335
9.
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection.
AIDS
; 37(15): 2297-2304, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37702421
10.
Identification of 2-(4-N,N-Dimethylaminophenyl)-5-methyl-1-phenethyl-1H-benzimidazole targeting HIV-1 CA capsid protein and inhibiting HIV-1 replication in cellulo.
BMC Pharmacol Toxicol
; 23(1): 43, 2022 06 28.
Article
in English
| MEDLINE | ID: mdl-35765101
11.
Nef Obtained from Individuals with HIV-1 Vary in Their Ability to Antagonize SERINC3- and SERINC5-Mediated HIV-1 Restriction.
Viruses
; 13(3)2021 03 06.
Article
in English
| MEDLINE | ID: mdl-33800773
12.
CD9 and ITGA3 are regulated during HIV-1 infection in macrophages to support viral replication.
Virology
; 562: 9-18, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34242748
13.
Emergence of monoclonal antibody b12-resistant human immunodeficiency virus type 1 variants during natural infection in the absence of humoral or cellular immune pressure.
J Gen Virol
; 91(Pt 5): 1354-64, 2010 May.
Article
in English
| MEDLINE | ID: mdl-20053822
14.
Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection.
J Virol
; 82(16): 7932-41, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18524815
15.
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing.
Antiviral Res
; 146: 139-145, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28844749
16.
Low level of HIV-1 evolution after transmission from mother to child.
Sci Rep
; 4: 5079, 2014 May 28.
Article
in English
| MEDLINE | ID: mdl-24866155
17.
HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag.
PLoS One
; 8(12): e81235, 2013.
Article
in English
| MEDLINE | ID: mdl-24339913
18.
Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity.
Virology
; 397(1): 224-30, 2010 Feb 05.
Article
in English
| MEDLINE | ID: mdl-19945135
19.
Changing sensitivity to broadly neutralizing antibodies b12, 2G12, 2F5, and 4E10 of primary subtype B human immunodeficiency virus type 1 variants in the natural course of infection.
Virology
; 390(2): 348-55, 2009 Aug 01.
Article
in English
| MEDLINE | ID: mdl-19539340
20.
Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
J Virol
; 81(2): 525-31, 2007 Jan.
Article
in English
| MEDLINE | ID: mdl-17079299